Compliance Deadlines Clause Samples

The Compliance Deadlines clause establishes specific timeframes within which parties must fulfill certain obligations or meet regulatory requirements outlined in the agreement. Typically, it details the exact dates or periods by which actions such as submitting reports, completing deliverables, or adhering to legal standards must be completed. By clearly defining these deadlines, the clause ensures accountability and helps prevent delays or disputes related to untimely performance.
Compliance Deadlines. 1. Allergan must be in full compliance with the provisions included in Section IV of this Agreement within 180 days after the Effective Date. Nothing herein shall be construed as permitting or requiring Allergan to avoid existing legal obligations.
View SourceView Similar (2)
Compliance Deadlines. 1. Endo must be in full compliance with the provisions included in this Consent Judgment by the date it is entered. Nothing herein shall be construed as permitting Endo to avoid existing legal obligations.
View SourceView Similar (2)
Compliance Deadlines. 1. As of the Petition Date, Mallinckrodt must be in full compliance with the provisions included in this Agreement with the exception of the provisions in Section V (“Public Access to Mallinckrodt Documents”).
View Source
Compliance Deadlines. 1. Within [#] days, Teva must be in full compliance with the provisions included in Sections [X-Y] of this Consent Judgment. 2. Within [#] days, Teva must be in full compliance with all other remaining provisions of this Consent Judgment.
View Source
Compliance Deadlines. 1. ▇▇▇▇▇▇▇ must be in full compliance with the provisions included this Agreement by the Effective Date. Nothing herein shall be construed as permitting ▇▇▇▇▇▇▇ to avoid existing legal obligations. COURT OF THE STATE OF NEW YORK COUNTY OF SUFFOLK IN RE OPIOID LITIGATION This document relates to: The County of Suffolk, New York v. Purdue Pharma L. P., Case No. 400001/2017 The County of Nassau, New York v. Purdue Pharma L. P., Case No. 400008/2017 Index No. 400000/2017 ▇▇▇. ▇▇▇▇▇ ▇▇▇▇▇▇▇▇ IT IS HEREBY STIPULATED AND AGREED, by and between the undersigned, counsel of record for Plaintiffs Suffolk County, New York, Nassau County, New York, and for Defendants ▇▇▇▇▇▇▇ & ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇ Pharmaceuticals, Inc., Ortho-▇▇▇▇▇▇-▇▇▇▇▇▇▇ Pharmaceuticals, Inc., and ▇▇▇▇▇▇▇ Pharmaceutica, Inc. (collectively, “▇▇▇▇▇▇▇”), that, pursuant to C.P.L.R. 3217, the following actions are hereby voluntarily discontinued with prejudice as to ▇▇▇▇▇▇▇ only, without costs as to any party against the other: 1. The County of Suffolk, New York v. Purdue Pharma L. P., Case No. 400001/2017; 2. The County of Nassau, New York v. Purdue Pharma L. P., Case No. 400008/2017. Dated: June , 2021 New York, New York O'MELVENY & ▇▇▇▇▇ LLP /s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ (admitted pro hac vice) ▇▇▇ ▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇ ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Phone: (▇▇▇) ▇▇▇-▇▇▇▇ NAPOLI ▇▇▇▇▇▇▇▇ PLLC _________________________ ▇▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇ Napoli ▇▇▇▇▇▇▇▇ PLLC ▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇ ▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Phone: (▇▇▇) ▇▇▇-▇▇▇▇
View Source
Compliance Deadlines. 1. ▇▇▇▇▇▇▇ must be in full compliance with the provisions included this Agreement by the Effective Date. Nothing herein shall be construed as permitting ▇▇▇▇▇▇▇ to avoid existing legal obligations.
View Source

Related to Compliance Deadlines

  • Reporting of Compliance Matters (a) The Sub-Adviser shall promptly provide to the Trust’s Chief Compliance Officer (“CCO”) the following documents: (i) copies of all SEC examination correspondences, including correspondences regarding books and records examinations and “sweep” examinations, issued during the term of this Agreement, in which the SEC identified any concerns, issues or matters (such correspondences are commonly referred to as “deficiency letters”) relating to any aspect of the Sub-Adviser’s investment advisory business and the Sub-Adviser’s responses thereto; (ii) a report of any material violations of the Sub-Adviser’s Compliance Program or any “material compliance matters” (as such term is defined in Rule 38a-1 under the ▇▇▇▇ ▇▇▇) that have occurred with respect to the Sub-Adviser’s Compliance Program; (iii) a report of any material changes to the policies and procedures that compose the Sub-Adviser’s Compliance Program; (iv) a copy of the Sub-Adviser’s chief compliance officer’s report (or similar document(s) which serve the same purpose) regarding his or her annual review of the Sub-Adviser’s Compliance Program, as required by Rule 206(4)-7 under the Advisers Act; and (v) an annual (or more frequently as the Trust’s CCO may reasonably request) representation regarding the Sub-Adviser’s compliance with Paragraphs 7 and 8 of this Agreement. (b) The Sub-Adviser shall also provide the Trust’s CCO with: (i) reasonable access to the testing, analyses, reports and other documentation, or summaries thereof, that the Sub-Adviser’s chief compliance officer relies upon to monitor the effectiveness of the implementation of the Sub-Adviser’s Compliance Program; and (ii) reasonable access, during normal business hours, to the Sub-Adviser’s facilities for the purpose of conducting pre-arranged on-site compliance related due diligence meetings with personnel of the Sub-Adviser.

  • Compliance Review During the Term, Developer agrees to permit the GLO, HUD, and/or a designated representative of the GLO or HUD to access the Property for the purpose of performing Compliance-Monitoring Procedures. In accordance with GLO Compliance-Monitoring Procedures, the GLO or HUD will periodically monitor and audit Developer’s compliance with the requirements of this Agreement, the CDBG-DR Regulations, the CDBG Multifamily Rental Housing Guidelines, and any and all other Governmental Requirements during the Term. In conducting any compliance reviews, the GLO or HUD will rely primarily on information obtained from Developer’s records and reports, on-site monitoring, and audit reports. The GLO or HUD may also consider other relevant information gained from other sources, including litigation and citizen complaints. 5.04 HAZARDOUS MATERIALS: INDEMNIFICATION

  • CONTRACT COMPLIANCE REQUIREMENT The HUB requirement on this Contract is 0%. The student engagement requirement of this Contract is 0 hours. The Career Education requirement for this Contract is 0 hours. Failure to achieve these requirements may result in the application of some or all of the sanctions set forth in Administrative Policy 3.10, which is hereby incorporated by reference.

  • Compliance Statement If a Plan Sponsor or Eligible Organization receives a compliance statement under VCP, the compliance statement is binding upon the Service and the Plan Sponsor or Eligible Organization as provided in section 10.09.

  • Reporting Covenant Required Complies Monthly financial statements with Compliance Certificate Monthly within 30 days Yes No Annual financial statement (CPA Audited) FYE within 120 days Yes No Board Projections FYE within 30 days Yes No A/R & A/P Agings Monthly within 30 days Yes No Transaction Report Weekly; or Monthly within 30 days if Streamline Eligible Yes No Deferred Revenue Reports Monthly within 30 days Yes No